chronic hepatitis

Also found in: Dictionary, Thesaurus, Acronyms, Encyclopedia.
Related to chronic hepatitis: Chronic Hepatitis B

chron·ic hep·a·ti·tis

any of several types of hepatitis persisting for longer than 6 months, often progressing to cirrhosis.
Farlex Partner Medical Dictionary © Farlex 2012

chronic hepatitis

Inflammation of the liver that does not improve within 6 months, excluding primary biliary cirrhosis, primary sclerosing cholangitis, alpha1 antitrypsin deficiency and Wilson’s disease. 

Autoimmune hepatitis, drug-induced hepatitis, HBV, HCV, HDV, chronic hepatitis of unknown origin (cryptogenic hepatitis).

Histologic clues for aetiology of chronic hepatitis
Viruses—Ground glass, fat, lymphoid aggregates, lymphocytosis, low grade.
Autoimmune—Plasma cells, rosetting, florid activity.
Drugs—Eosinophils, granulomas, mixed cellular reaction.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.

chronic hepatitis

Hepatology Inflammation of the liver that continues without improvement for ≥ 6 months. See Cirrhosis. Cf Acute hepatitis.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.

chron·ic hep·a·tit·is

(kronik hep-ă-tītis)
One of several types of liver disease persisting for longer than 6 months, often progressing to cirrhosis.
Medical Dictionary for the Health Professions and Nursing © Farlex 2012

Chronic hepatitis

Long lasting inflammation of the liver due to viruses or other causes.
Gale Encyclopedia of Medicine. Copyright 2008 The Gale Group, Inc. All rights reserved.
References in periodicals archive ?
Splenic artery pulsatility index is a simple, non-invasive and reproducible technique for assessing hepatic fibrosis in patients with chronic hepatitis C and can reduce the number of staging liver biopsies.
Suzuki et al., "Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C," Hepatology, vol.
Chronic hepatitis C virus (HCV) disease burden and cost in the United States.
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: A 5-year open-label follow-up study.
Treatment of chronic hepatitis C in polytransfusedthalassaemic patients: a meta?analysis.
Patients with chronic hepatitis C had a nearly 25-fold greater risk of being hospitalized with liver-related conditions, compared with other health system patients.
Chronic hepatitis B is usually defined by the presence of hepatitis B surface antigen in the blood or serum for longer than 6 months.
The program aims to improve the capacity of health care providers and stakeholder groups to reduce the burden of chronic hepatitis B in Asian American and other at-risk communities through increased hepatitis B education, screening, vaccination, and linkage to care.
So, the logical question arises for clinicians, should all patients with diagnosed NAFLD be screened for chronic hepatitis C?
Medivir AB (STO:MVIRB.ST), a research-based pharmaceutical company focused on infectious diseases, announced today the approval by the Russian Ministry of Health of Sovriad (simeprevir) for the treatment of chronic hepatitis C genotype 1 infection in combination with pegylated interferon and ribavirin in HCV genotype 1 and 4 infected patients with compensated liver disease, including cirrhosis.
Chronic hepatitis B remains the most common serious health problem in the world, especially in the Asia Pacific region.

Full browser ?